Sun Pharma: $11.75 Billion Organon Acquisition Expands Global Scale And Women’s Health Leadership

Sun Pharmaceutical Industries Limited announced a definitive agreement to acquire Organon & Co. in an all-cash transaction valued at an enterprise value of $11.75 billion, with Organon shareholders set to receive $14 per share.Read More